An interventional study of Weiqi decotion in Gastritis, sponsored by Shanghai University of Traditional Chinese Medicine. Completed at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-04-19.
Sponsored by Shanghai University of Traditional Chinese Medicine · Not applicable, Interventional, and Treatment
The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.
196 studies on the registry are indexed under Gastritis; 42 are open to participants now.
This study's enrollment of 200 is close to the median of 200 across 113 interventional studies indexed under Gastritis.
Browse Gastritis studies →Shanghai University of Traditional Chinese Medicine is the lead sponsor of 99 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Weiqi decotion
Drug: Weiqi decotion
Decoction ,two times a day
Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change
Time frame: 12 weeks
Indicates of liver and renal function
Time frame: 12 weeks
This study is completed, as verified in Aug 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai University of Traditional Chinese Medicine